Detalhe da pesquisa
1.
RNA aggregates harness the danger response for potent cancer immunotherapy.
Cell;
187(10): 2521-2535.e21, 2024 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38697107
2.
[Withdrawal of life sustaining treatment in the ICU - different doctors act differently]. / Hur livsuppehållande behandling avbryts på Iva läkare gör olika.
Lakartidningen;
1212024 Jun 04.
Artigo
em Sueco
| MEDLINE
| ID: mdl-38832570
3.
Pompe disease gene therapy.
Hum Mol Genet;
20(R1): R61-8, 2011 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21518733
4.
Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation.
Mol Ther Methods Clin Dev;
30: 303-314, 2023 Sep 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37601414
5.
mRNA aggregates harness danger response for potent cancer immunotherapy.
medRxiv;
2023 Mar 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36993772
6.
Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy.
Ann Transl Med;
7(13): 290, 2019 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31392202
7.
[A retrospective analysis of the management of unconscious patients from the emergency room (ER) to intensive care (ICU) at Södersjukhuset]. / Fler medvetslösa patienter bör intuberas för säkrad luftväg - Många medvetslösa vårdas också för kort tid på IVA möjliga donatorer missas, visar retrospektiv analys.
Lakartidningen;
1152018 09 07.
Artigo
em Sueco
| MEDLINE
| ID: mdl-30204227
8.
[Swedish patients can receive better anesthesiologic care. Fluid therapy and oxygen administration in major bowel surgery are not optimal according to a questionnaire]. / Svenska patienter kan få bättre anestesiologisk vård. Vätsketerapi och syrgasleverans vid stor tarmkirurgi är inte optimal, visar enkät.
Lakartidningen;
108(40): 1963-7, 2011.
Artigo
em Sueco
| MEDLINE
| ID: mdl-22111237
9.
A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform.
Mol Ther Methods Clin Dev;
3: 16031, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27222839
10.
Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning.
Hum Gene Ther Clin Dev;
26(3): 185-93, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26390092
11.
A simplified purification protocol for recombinant adeno-associated virus vectors.
Mol Ther Methods Clin Dev;
1: 14034, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26015974
12.
Phase I/II trial of adeno-associated virus-mediated alpha-glucosidase gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes.
Hum Gene Ther;
24(6): 630-40, 2013 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23570273
13.
Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa.
Hum Gene Ther Clin Dev;
24(1): 23-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23692380
14.
Phase I/II trial of diaphragm delivery of recombinant adeno-associated virus acid alpha-glucosidase (rAAaV1-CMV-GAA) gene vector in patients with Pompe disease.
Hum Gene Ther Clin Dev;
25(3): 134-63, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25238277